| [1] |
Zhang Z, Lei J, Shao X, et al. Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China[J]. Chest, 2019, 155(2):342-353.
|
| [2] |
Zhai Z, Kan Q, Li W, et al. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients′ Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study[J]. Chest, 2019, 155(1):114-122.
|
| [3] |
Margaglione M, Grandone E. Population genetics of venous thromboembolism. A narrative review[J]. Thromb Haemost, 2011, 105(2):221-231.
|
| [4] |
Zhu T, Ding Q, Bai X, et al. Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group[J]. Haematologica, 2011, 96(7):1033-1040.
|
| [5] |
Tang L, Wang HF, Lu X, et al. Common genetic risk factors for venous thrombosis in the Chinese population[J]. Am J Hum Genet, 2013, 92(2):177-187.
|
| [6] |
Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism[J]. Thromb Haemost, 2015, 114(5):901-909.
|
| [7] |
刘凤林, 张太平. 中国普通外科围手术期血栓预防与管理指南[J]. 中国实用外科杂志, 2016, 36(5):469-474.
|
| [8] |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1087.
|
| [9] |
《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36):2861-2888.
|
| [10] |
Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e419S-e496S.
|
| [11] |
Streiff MB, Holmstrom B, Ashrani A, et al. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015[J]. J Natl Compr Canc Netw, 2015, 13(9):1079-1095.
|
| [12] |
Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients[J]. Blood, 2010, 116(24):5377-5382.
|
| [13] |
中华医学会血液学分会血栓与止血学组. 易栓症诊断中国专家共识(2012年版)[J]. 中华血液学杂志, 2012, 33(11):982.
|
| [14] |
Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia[J]. Br J Haematol, 2010, 149(2):209-220.
|
| [15] |
Reynaud Q, Lega JC, Mismetti P, et al. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis[J]. Autoimmun Rev, 2014, 13(6):595-608.
|
| [16] |
Moulis G, Audemard-Verger A, Arnaud L, et al. Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis[J]. Autoimmun Rev, 2016, 15(3):203-209.
|
| [17] |
Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis[J]. J Thromb Haemost, 2009, 7(10):1737-1740.
|
| [18] |
Clinical and Laboratory Standards Institute.Laboratory Testing for the Lupus Anticoagulant H60-A; Approved Guideline, 2014, Vol. 34 No. 6.[M]. Wayne, 2014.
|
| [19] |
中国医师协会心血管内科医师分会血栓防治专业委员会 《中华医学杂志》编辑委员会. 肝素诱导的血小板减少症中国专家共识(2017)[J]. 中华医学杂志, 2018, 98(6):408-417.
|
